Standard Bank has announced a large South African debt underwriting deal with the conclusion of Aspens’ A$900m acquisition of the Australian pharmaceutical business of Sigma.
Standard Bank was mandated lead arranger, debt advisor and underwriter of Aspen’s acquisition of Sigma’s pharmaceutical division, after the deal received approval from Sigma’s shareholders in Australia. The transaction price was A$900m, with Standard Bank underwriting A$800m of this facility.
Aspen is South Africa’s leading pharmaceutical company. It is a substantial player in emerging markets, supplying branded and generic pharmaceuticals in about 100 countries, as well as consumer and nutritional products in selected territories.
David Renwick, director and head of diversified lending and leverage at Standard Bank Corporate and Investment Banking, said: “[The deal’s] key attributes are that it demonstrates Standard Bank’s ability to support South African corporate clients in their expansion abroad, as well as a capability in handling cross-border deals. I believe our ability and willingness to provide large underwriting underlines Standard Bank’s commitment to Aspen as its client.”
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more